Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impaired Bone Morphogenetic Protein Receptor II Signaling in a Transforming Growth Factor-β–Dependent Mouse Model of Pulmonary Hypertension and in Systemic Sclerosis

21 Jan 2015

Abstract excerpt

RATIONALE: Up to 10% of patients with systemic sclerosis (SSc) develop pulmonary arterial hypertension (PAH). This risk persists throughout the disease and is time dependent, suggesting that SSc is a susceptibility factor. Outcome for SSc-PAH is poor compared with heritable or idiopathic forms, despite clinical and pathological similarities. Although susceptibility in heritable PAH and idiopathic PAH is strongly...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Connective Tissue Growth Factor Research
Share to Pulmonary Hypertension Research and Treatments
Share to Systemic Sclerosis and Related Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25606692
DOI: 10.1164/rccm.201408-1464oc

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impaired Bone Morphogenetic Protein Receptor II Signaling in a Transforming Growth Factor-β–Dependent Mouse Model of Pulmonary Hypertension and in Systemic SclerosisPMID 25606692Read ↗

Endothelial injury in a transforming growth factor β-dependent mouse model of scleroderma induces pulmonary arterial hypertension.Semantic proximity Read ↗

An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma.Semantic proximity Read ↗

Restoring BMPRII functions in pulmonary arterial hypertension: opportunities, challenges and limitations.Semantic proximity Read ↗

Bone morphogenetic protein signalling in pulmonary arterial hypertension: revisiting the BMPRII connectionSemantic proximity Read ↗

Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling?Semantic proximity Read ↗

BMP type II receptor as a therapeutic target in pulmonary arterial hypertensionSemantic proximity Read ↗

Identification of Optimal Mouse Models of Systemic Sclerosis by Interspecies Comparative GenomicsSemantic proximity Read ↗

The role of TGF-β or BMPR2 signaling pathway-related miRNA in pulmonary arterial hypertension and systemic sclerosisSemantic proximity Read ↗

Recent advances in animal models of systemic sclerosisSemantic proximity Read ↗

Transforming growth factor-beta in systemic sclerosis sclerodermaSemantic proximity Read ↗

Epigenetic repression of bone morphogenetic protein receptor II expression in sclerodermaSemantic proximity Read ↗

Differential IL‐1 signaling induced by BMPR2 deficiency drives pulmonary vascular remodelingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.